Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Osel DevicesNSE:OSELDEVICE -4.88%49 ROE % is 14.53% as of Mar. 2026, which is 54% below its 10-year median of 31.85. GuruFocus rates NSE:OSELDEVICE with a GF Score™ of 49/100. The stock has 6 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Osel Devices ranks better than 89.36% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Osel Devices's annualized net income for the quarter that ended in Mar. 2026 was ₹281 Mil. Osel Devices's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₹1,931 Mil. Therefore, Osel Devices's annualized ROE % for the quarter that ended in Mar. 2026 was 14.53%.
The historical rank and industry rank for Osel Devices's ROE % or its related term are showing as below:
NSE:OSELDEVICE'
s ROE % Range Over the Past 10 Years
Min: 17.73 Med: 31.85 Max: 67.41
Current: 17.73
During the past 6 years, Osel Devices's highest ROE % was 67.41%. The lowest was 17.73%. And the median was 31.85%.
NSE:OSELDEVICE's ROE % is ranked better than 89.36% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 2.68
vs NSE:OSELDEVICE: 17.73
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Osel Devices ROE % Related Terms
Osel Devices ROE % Historical Data
* Premium members only.
The historical data trend for Osel Devices's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Osel Devices's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osel Devices ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osel Devices's ROE % distribution charts can be found below:
* The bar in red indicates where Osel Devices's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Osel Devices (NSE:OSELDEVICE) has a ROE % of 14.53% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Osel Devices and its competitors. This is 54% below median its historical median of 31.85. Over the past decade, Osel Devices' ROE % has ranged from 17.73 to 67.41. According to the industry distribution chart, Osel Devices ranks #85 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 10.6%.
Is Osel Devices' ROE % too high?
Osel Devices' current ROE % of 14.53% is 54% below median its 10-year median of 31.85. Over the past 10 years, this metric has ranged from a low of 17.73 to a high of 67.41. The Medical Devices & Instruments industry median ROE % is 2.68. Osel Devices' value of 14.53% is 442.2% above this industry median. Based on the distribution chart, Osel Devices ranks #85 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Osel Devices has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Osel Devices' ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Osel Devices ranks #85 out of 799 companies for ROE %. This places Osel Devices in the top 11% of its industry — outperforming the majority of peers. The industry median ROE % is 2.68. Osel Devices' value of 14.53% is 442.2% above this benchmark. Historically, Osel Devices' own ROE % has ranged from 17.73 to 67.41 over the past decade. While the company's 10-year median is 31.85 vs. the industry median of 2.68, Osel Devices has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.68, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Osel Devices's current ROE % of 14.53% is 442.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Osel Devices and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osel Devices's current ROE % is 14.53%, which is 54% below median its own 10-year median of 31.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osel Devices stock overvalued right now?
Osel Devices (NSE:OSELDEVICE) has a current ROE % of 14.53%. The current ROE % is 14.53%, which is 54% below median its 10-year median of 31.85 and 442.2% above the Medical Devices & Instruments industry median of 2.68. Osel Devices' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Osel Devices (NSE:OSELDEVICE), the current ROE % is 14.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Osel Devices Ltd is engaged in the manufacture, trade, retail, wholesale, import, export, warehousing, storage, distribution, assembly, repair, maintenance, integration, operation, testing, installation, and resale of hearing aids and LED display components, parts, and accessories. The company also carries out research and development activities related to all kinds of hearing aids, components, parts, and accessories. it offers variuos products including advanced hearing aids designed to improve auditory experience and LED solutions tailored to various industries, while also distributing Mobile products across India. it generates majority of revenue from hearing aids.
49GF Score
Get the complete analysis for NSE:OSELDEVICE
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:OSELDEVICE has been successfully added to your 
